<?xml version="1.0" encoding="UTF-8"?>
<ref id="B5-molecules-24-01552">
 <label>5.</label>
 <element-citation publication-type="web">
  <person-group person-group-type="author">
   <collab>European Medicines Agency</collab>
  </person-group>
  <article-title>Silibinin-
   <italic>C</italic>-2â€²,3-dihydrogensuccinate, Disodium Salt for the Prevention of Recurrent Hepatitis C in Liver Transplant Recipients
  </article-title>
  <comment>Available online: 
   <ext-link ext-link-type="uri" xlink:href="https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu310828" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu310828</ext-link>
  </comment>
  <date-in-citation content-type="access-date" iso-8601-date="2019-03-23">(accessed on 23 March 2019)</date-in-citation>
 </element-citation>
</ref>
